What Nform does

Nform is a Canadian private company headquartered in Edmonton, Alberta, founded in 2003, that develops and supplies oral fluid rapid drug testing devices. The company's core product is a non-invasive oral fluid screening device designed to deliver lab-quality drug screening results in real time at decentralized testing sites, eliminating the need to ship samples to external laboratories and reducing turnaround time for employers and clinical users. The device is positioned for workplace, occupational health, and pre-employment drug screening use cases where immediacy and decentralized deployment matter more than centralized lab throughput.

Nform's go-to-market is channel-dependent: the company distributes its devices through a strategic partnership with Origin One, whose occupational health platform integrates Nform's oral fluid testing devices and exposes them to employers, third-party administrators (TPAs), and clinics. Pricing is not publicly disclosed, and the company generates revenue through hardware sales of its testing devices. No information is available on management team, ownership, funding history, regulatory clearances, patents, certifications, or financial performance. The firmographic description also categorizes Nform as an "internet of things" company, which is not corroborated by the product data supplied; this inconsistency is noted but unresolved within the available evidence.

The available evidence base is narrow: a single strategic event (the Origin One partnership and integrated product launch dated 2025-11-05), no disclosed customers or case studies, no marketing or distribution channels beyond Origin One, and no headcount or revenue figures beyond a 11-50 employee band. Investors should weight analytical conclusions accordingly.

Name

Nform

Legal name

nform

Website

https://nform.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Nform is an Edmonton-based Canadian company that develops oral fluid rapid drug testing devices delivering real-time, lab-quality screening at decentralized sites, distributed via Origin One's occupational health platform to employers, TPAs, and clinics.

Ownership category

akta.pro rank

Product category

Workplace Drug Screening Devices

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)

akta.pro secondary industry

Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

Keywords

• Oral fluid drug testing
• Workplace drug screening
• Occupational health testing
• Rapid drug testing devices
• Decentralized drug screening

Headquarters

HQ city

Edmonton

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Oral Fluid Drug Testing Devices: Sale of rapid drug testing devices for occupational health applications, distributed through partnership integration with Origin One's platform for employers, TPAs, and clinics.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Nform develops and sells oral fluid rapid drug testing devices that deliver lab-quality drug screening results in real time at decentralized testing sites. The devices are distributed through a strategic integration with Origin One's occupational health platform, enabling employers, third-party administrators (TPAs), and clinics to conduct point-of-collection drug screening without traditional lab processing or waiting periods.

Product overview

nform offers oral fluid rapid drug testing devices as its core product offering. The company provides mobile drug testing solutions that deliver lab-quality results in real-time across decentralized testing locations. The product integrates with occupational health platforms to serve employers, third-party administrators (TPAs), and clinics.

Differentiator

Problem solved

Functional benefit

Products and services

• Oral Fluid Rapid Drug Tests Rapid drug testing devices that use oral fluid samples to deliver lab-quality drug screening results in real time at decentralized testing sites, eliminating the need for traditional laboratory processing. Designed for occupational health applications and sold through Origin One's occupational health platform to employers, third-party administrators (TPAs), and clinics.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Partnerships

One partnership is on record.

• Origin OnecoreTechnology or Integration · 5 November 2025Origin One integrated nform's oral fluid drug testing devices into its occupational health platform. This integration enables real-time, lab-quality drug screening results across decentralized testing sites, streamlining workflows for employers, TPAs, and clinics.

Expansion highlights3 records

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is a major incumbent employer drug testing service provider, representing the legacy lab-based workflow that decentralized oral fluid rapid tests like Nform's are positioned to disrupt.
• Dräger: Dräger produces workplace drug and alcohol testing instruments (e.g., Alcotest, DrugTest) used by employers and law enforcement, placing it in the same occupational drug screening category as Nform.
• Laboratory Corporation of America (Labcorp): Labcorp operates one of the largest workplace drug testing laboratory networks in the US, making it the dominant centralized incumbent whose customers are a natural migration path for Nform's faster, decentralized oral fluid platform.
• Abbott (formerly Alere): Abbott operates a broad POCT and rapid diagnostics portfolio, including workplace toxicology offerings, that overlap with Nform's category but at vastly greater scale and across many other diagnostic segments.

Direct peers

• Securetec Detektions-Systeme: Securetec develops saliva- and sweat-based rapid drug detection systems used at the point of collection, making it a directly comparable POCT drug screening peer to Nform.
• Premier Biotech: Premier Biotech manufactures and distributes oral fluid drug testing devices and panels for workplace and clinical use, making it the most direct head-to-head comparable to Nform's core product line.
• OraSure Technologies: OraSure is a pioneer in oral fluid collection and rapid diagnostic testing, including drug-of-abuse and infectious disease panels — a direct technology and use-case analog to Nform's oral fluid drug test platform.
• Neogen Corporation: Neogen's drug testing division produces rapid screening devices used in workplace and clinical settings, including analyte panels comparable to those in Nform's oral fluid offering.
• Psychemedics Corporation: Psychemedics is a specialty drug testing company using an alternative sample (hair) for workplace screening, making it a closely comparable specialty drug testing peer from a customer and channel perspective.
• Omega Laboratories: Omega Laboratories is a specialty toxicology lab focused on workplace and clinical drug testing, competing in the same employer and TPA buyer segment that Nform targets with its decentralized oral fluid devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/nform
• Facebookfacebook.com/nformux
• LinkedInlinkedin.com/company/nform

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nform